Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Invitation to Webcast of Bionor Pharma Q3 2014 Results 4 November

Financial .2014

Bionor Pharma ASA (OSE:BIONOR) will announce its third quarter 2014 results Tuesday 4 November 2014 at 7.00 CET.

Invitation to Webcast of Bionor Pharma Q3 2014 Results 4 November

Financial .2014

Bionor Pharma ASA (OSE:BIONOR) will announce its third quarter 2014 results Tuesday 4 November 2014 at 7.00 CET.

Mandatory Notification of Trade

Financial .2014

(Oslo, Norway, 14 October 2014) Bionor Pharma ASA Deputy Chairman Øystein Soug’s directly owned company Abakus Invest AS has on 13 October bought 79 545 shares in Bionor Pharma from Øystein Soug at NOK 2,38.Abakus Invest AS holds 107,205 shares after the transaction.

Go to news section

Featured content